Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00941993 · ClinicalTrials.gov registry record · NA

Anesthetic Effect of Lidocaine/Epinephrine Solution Delivered Via Iontophoresis to External Auditory Apparatus

A NA study, sponsored by Integra LifeSciences Corporation.

Completed
Registry status
NA
Development phase
109
Enrollment target

NCT00941993: Completed NA study, sponsored by Integra LifeSciences Corporation.

NCT00941993 is a NA study that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 109 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00941993, a NA study, has completed, sponsored by Integra LifeSciences Corporation.

COMPLETED
Registry status
NA
Development phase
109 participants
Enrollment target

Study Summary

This is a non-randomized, multicenter, prospective, clinical study intended to evaluate the effectiveness of a method for iontophoretic delivery of a buffered lidocaine/epinephrine solution for provision of tympanic membrane anesthesia in patients who are indicated for an ear procedure requiring penetration of the tympanic membrane, including, but not limited to, myringotomy, tympanocentesis with culture or tympanostomy with tube placement.

Primary Outcome

Investigator performed a gentle tap of the tympanic membrane to assess whether adequate anesthesia was achieved following local anesthesia by iontophoresis. All subjects for which an ear procedure was attempted were considered to have achieved anesthesia effectiveness.

Interventions

  • DEVICE Iontophoresis System (Acclarent)

Trial Details

FieldValue
Enrollment Target 109 participants
Start Date 2008-04
Est. Completion 2011-01
Phase NA
Integra LifeSciences Corporation

60 total trials

What the finished NCT00941993 record still lists

NCT00941993 is an interventional study that assigns participants to a tested intervention. The registered 109 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 1 intervention - of which Iontophoresis System (Acclarent) is the first listed.

NCT00941993 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00941993 about?

NCT00941993 is a clinical study titled "Anesthetic Effect of Lidocaine/Epinephrine Solution Delivered Via Iontophoresis to External Auditory Apparatus". This is a non-randomized, multicenter, prospective, clinical study intended to evaluate the effectiveness of a method for iontophoretic delivery of a buffered lidocaine/epinephrine solution for provision of tympanic membrane anesthesia in patients who are indicated for an ear procedure requiring pen...

What is the current status of trial NCT00941993?

This trial is currently completed. It is a NA study. The enrollment target is 109 participants. The study started on 2008-04. Estimated completion is 2011-01.

What interventions are being tested in trial NCT00941993?

The interventions under investigation include: Iontophoresis System (Acclarent) (DEVICE).

Who is sponsoring clinical trial NCT00941993?

This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00941993's enrollment target sits among peer trials

109 825th of 2000 higher than 1,176 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02421380 · 109 participants · NA

    Characterization of Hyperpolarized Pyruvate MRI Reproducibility

  • NCT04526600 · 109 participants · NA

    Fidgeting and Attentional and Emotional Regulation in ADHD

  • NCT04835584 · 109 participants · Phase 1

    KRT-232 and TKI Study in Chronic Myeloid Leukemia

  • NCT06626516 · 109 participants · Phase 1

    Tebentafusp-tebn With LDT in Metastatic UM

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00941993, the US trial registry maintained by the National Library of Medicine. NCT00941993 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.